Laurent Ayache

McDermott Will & Emery (Paris)
Lawyer (Partner)

Laurent Ayache is a partner in the law firm of McDermott Will & Emery LLP, based in its Paris office. His practice focuses on the areas of Public, Administrative and Regulatory Law, including issues in connection with competition and public sector matters. Laurent is a member of the Paris Bar (January 2005). He has received a master in public law and economics (DESS de droit public économique) in 2003 and a master in European corporate law (DESS de droit européen des affaires) in 2004. Laurent teaches a course in contracts and administrative law (Theory of Administrative Law) in the undergraduate program in Law and Economic Activities at the University of Paris I (Pantheon-Sorbonne) and a course on law and hydraulic energy in an Energy Law program at University of Paris I. Laurent authored a book entitled Droit de la concurrence et secteur public (Antitrust Law and the Public Sector) published by LexisNexis, is a contributor to the annual review on government grants, aid and subsidies in the Quarterly European Law Review and is a regulator contributor to the Antitrust, Regulation and Public Sector section of the Contracts, Antitrust and Consumption law review. He has also authored numerous articles on government contracts.

Auteurs associés

Autorité de la concurrence (Paris)
Compass Lexecon (Paris)
McDermott Will & Emery (Paris)
McDermott Will & Emery (Paris)
European Company Lawyers Association (ECLA)
McDermott Will & Emery (Paris)
Tera Consultants
Paris Commercial Court

Articles

52 Bulletin

Sabine Nauges, Daniel von Brevern, Christian Krohs, Andrea L. Hamilton, David Henry, Wilko Van Weert, Laurent Ayache The EU Commission adopts a temporary framework allowing Member States to grant State aid to businesses to help them face the COVID-19 crisis

52

On 19 March 2020, the European Commission adopted a temporary framework that allows Member States to grant certain State aid to businesses to help them face the economic and financial consequences of the Coronavirus (COVID-19) health crisis. In the wake of this decision—and in a record time of (...)

627 Revue

Envoyer un message